COSA 2018: Genomics provide hope for those with “one in a million” cancer diagnosis
New research has shown that many Australians with rare cancers can benefit from genomic profiling.…
Browsing: rare cancers
New nuclear medicine method shows promise for better detection of neuroendocrine tumours
Researchers have shown that a new nuclear medicine procedure could safely and more effectively detect…
COSA 2017: How do we improve cancer care?
Professor Dorothy Keefe, from the University of Adelaide, presented at the Clinical Oncology Society of…
Researchers show the potential of precision medicine for treating rare cancers
For the first time, researchers have been able to identify effective treatments for patients with…
How we can overcome the lack of treatment options for rare cancers
Colman Taylor, University of Sydney and John Zalcberg, Monash University Rare cancers are just that:…
ESMO 2017: DNA Sequencing Could Open Up New Drug Indications for Patients with Rare Cancers
Thanks to DNA sequencing, patients with rare cancers for which no standard treatment is available…
In the first Neglected Cancers Awareness Week, Garvan Institute calls for improved outcomes for those affected by neglected cancers.
The Garvan Institute of Medical Research today launches the inaugural Neglected Cancers* Awareness Week (19-25…
One in 5 cancers diagnosed in the United States is a rare cancer
About one in five cancer diagnoses in the United States is a rare cancer, according…
How rare disease research is changing cancer treatment
Elaine Dunlop, Cardiff University Researching rare diseases and treatments can be a challenging task –…
New drug in development shows improved progression-free survival for patients with advanced metastatic midgut neuroendocrine tumours
A new therapy in development for the treatment of midgut neuroendocrine tumours, a rare type…